Search

Although neurocognitive, psychological and behavioural problems were noted for some patients during medical review, only 20% of patients were formally assessed.

This study advances our understanding of drug resistance in T-ALL and provides new markers for patient stratification.

This study contributes to our understanding of the genetic diversity of NMC, an important step towards finding therapeutic targets for a disease that is...

Acute Lymphoblastic Leukemia (ALL) occurring in the first year of life is rare.

The hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, which may lead to gene fusions.

In T-cell acute lymphoblastic leukemia (T-ALL) cytogenetic alterations juxtapose the LIM-domain-only-2 gene (LMO2) with T-cell receptor loci.

Glucocorticoids (GCs) are among the most important drugs for the treatment of acute lymphoblastic leukaemia (ALL).

Co-Head, Leukaemia Translational Research

Co-Head, Leukaemia Translational Research

Honorary Emeritus Fellow